Introducing way more signals! We've added more signal sources to capture the full customer journey.

Learn More!
ProSci

ProSci

ProSci Inc develops custom rabbit monoclonal antibodies for research in designing vaccines, diagnostics, therapeutics and related products. Customers provide ProSci with their antigen or target to design an antigen against and in three to four months, an ELISA report, 200ug of purified antibody for up to five clones, as well as the sequences is delivered with the option of additional production. ProSci recognizes that rabbit monoclonal antibodies are highly valuable because the rabbit immune system is particularly unique and generates a plethora of diverse antibodies and binding affinity optimization not found in other animals commonly used in research. The process of rabbit immunization generates a wide selection of B-lymphocytes as well as splenocytes and in comparison to mouse monoclonal antibodies, rabbit monoclonal antibodies can typically achieve binding affinities that are 10 to 100 times stronger. ProSci Inc has over 17 years of experience and specializes in custom polyclonal , monoclonal , and single domain antibody development and production. ProSci routinely takes on some of the most challenging targets including small molecule compounds, point mutations, post-translational modifications, splice variants and species-specific orthologs. The firm stands apart from competitors by ensuring every single client is provided with high quality technical assistance, competitive pricing, and highly customizable projects. ProSci Inc's antibodies have been widely published, appearing in many prestigious journals worldwide. Regardless of the complexity of the research project, the ProSci Inc team is ready and skilled to tailor its suite of services to the specific needs of each client's project. The firm's state-of-the-art facilities are equipped with the technology to handle immunogens in a wide array of forms including basic cells, pathological tissue samples or synthetic peptides. ProSci Inc's expertise and advanced technology positions the firm well to meet clients at every stage in the research process and deliver rabbit monoclonal antibody services with rapidity and reliability.

Last updated on

About ProSci

Founded

1998

Estimated Revenue

$1M-$10M

Employees

11-50

Funding / Mkt. Cap

$350K

Category

Industry

Biotechnology

Location

City

Poway

State

California

Country

United States
ProSci

ProSci

Find your buyer within ProSci

Tech Stack (27)

search